Replies to post #799485 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Everyone missed timelines, NWBO and/or MHRA apparently wanted data out to ten years before submitting to NICE. They finished global data collection on the randomized trial December 31, 2024. No bear or long predicted that. They continued to gather survival data beyond that, according to George’s email to someone here.

Blame them, not the peasants that tried to figure out what was going on by reading company PRs, media presentations, SEC filings, etc. We were told many dates, like 2021 from LG on BB.

[sukus]

No one takes you seriously with your meager $0.50 price forecasts.

This is not just a year two year Mr $0.50.

It is much more than that. If you own a company like this person said below, you know what I meant.

I'm hearing more and more,

"Ahmed, your trying to conquer too much"

I'm not playing the vc hype game,

I'm playing the 20 year Jensen Huang game

"Just a little more progress every day"

Others can outraise us on hype in a niche market, I'll build a category defining company pic.twitter.com/8rNQtbzqGJ

— Ahmed shubber (@ahmedshubber25) November 21, 2025